Canadian cannabis – one that could cement it as a key economic driver for our country. Amid rising geopolitical uncertainty, ...

Cannabis is restricted for recreational consumption, but scientific, research and medical applications are allowed. Britain’s ...

CBD-infused Products Market Expected to Grow at a CAGR of 30.6% from 2025 to 2032 REDDING, Calif., March 12, 2025 /PRNewswire/ -- According to a new market research report titled, 'CBD-infused ...

New Data Highlights Superior Efficacy and Tolerability of Avextra 10/10 in Treating Chemotherapy-Induced Neuropathic Pain News Release Bensheim, Germany – 13 March 2025 – At its annual congress in ...

2020 Medicines Act Amendment (Government Notice No. 586, Gazette No. 43347): CBD was ... from severe pharmaceutical regulations, allowing for limited usage in consumer food goods. Cannabis for ...

EQS-News: SynBiotic SE / Key word (s): Statement/Product Launch Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin 13.03.2025 / 11:14 ...

After years of campaigning for cannabis legalisation, activists are dismayed by the South African government's sudden ban on cannabis edibles.

Discover how terpenes work synergistically with cannabinoids to enhance medicinal effects, offering therapeutic benefits beyond what CBD and THC provide alone.

To date over thirty countries have established medical cannabis laws or strict guidelines for the use of cannabis-derived pharmaceuticals ... the effectiveness of CBD as a medical treatment ...

Avextra Unveils Promising Study Results at Major Pain Congress New Data Highlights Superior Efficacy and Tolerability of Avextra 10/10 in Treating Chemotherapy-Induced Neuropathic ...

Spring is here, bringing longer days, fresh blooms, and the perfect time to uplift your mood and enhance your well-being. To celebrate, Rare Cannabinoid Company is offering a BOGO 50% off deal on its ...